{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T22:53:47Z","timestamp":1779144827514,"version":"3.51.4"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":3901,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1016\/j.ymthe.2005.09.022","type":"journal-article","created":{"date-parts":[[2005,12,6]],"date-time":"2005-12-06T12:21:10Z","timestamp":1133871670000},"page":"374-381","source":"Crossref","is-referenced-by-count":27,"title":["Successful Treatment of UGT1A1 Deficiency in a Rat Model of Crigler\u2013Najjar Disease by Intravenous Administration of a Liver-Specific Lentiviral Vector"],"prefix":"10.1016","volume":"13","author":[{"given":"Pascal","family":"van der Wegen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rogier","family":"Louwen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali M.","family":"Imam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruvalic M.","family":"Buijs-Offerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maarten","family":"Sinaasappel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Grosveld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bob J.","family":"Scholte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2005.09.022_bib1","first-page":"169","article-title":"Congenital familial nonhemolytic jaundice with kernicterus","volume":"10","author":"Crigler","year":"1952","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymthe.2005.09.022_bib2","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/hep.510240205","article-title":"Current therapy for Crigler\u2013Najjar syndrome type 1: report of a world registry","volume":"24","author":"van der Veere","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.ymthe.2005.09.022_bib3","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/S0022-3468(03)00273-2","article-title":"Treatment of Crigler\u2013Najjar type 1 disease: relevance of early liver transplantation","volume":"38","author":"Schauer","year":"2003","journal-title":"J. Pediatr. Surg"},{"key":"10.1016\/j.ymthe.2005.09.022_bib4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1034\/j.1399-3046.2002.1p057.x","article-title":"Pediatric liver transplantation in metabolic disease: clinical decision making","volume":"6","author":"Shneider","year":"2002","journal-title":"Pediatr. Transplant"},{"key":"10.1016\/j.ymthe.2005.09.022_bib5","doi-asserted-by":"crossref","first-page":"24048","DOI":"10.1016\/S0021-9258(18)54390-8","article-title":"Molecular basis of multiple UDP-glucuronosyltransferase isoenzyme deficiencies in the hyperbilirubinemic rat (Gunn rat)","volume":"266","author":"Iyanagi","year":"1991","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.ymthe.2005.09.022_bib6","doi-asserted-by":"crossref","first-page":"26536","DOI":"10.1074\/jbc.271.43.26536","article-title":"Long term correction of bilirubin-UDP-glucuronosyltransferase deficiency in Gunn rats by administration of a recombinant adenovirus during the neonatal period","volume":"271","author":"Takahashi","year":"1996","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.ymthe.2005.09.022_bib7","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1172\/JCI119085","article-title":"Induction of central tolerance by intrathymic inoculation of adenoviral antigens into the host thymus permits long-term gene therapy in Gunn rats","volume":"98","author":"Ilan","year":"1996","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.ymthe.2005.09.022_bib8","first-page":"381","article-title":"Complete correction of hyperbilirubinemia in the Gunn rat model of Crigler\u2013Najjar syndrome type I following transient in vivo adenovirus-mediated expression of human bilirubin UDP-glucuronosyltransferase","volume":"3","author":"Askari","year":"1996","journal-title":"Gene Ther"},{"key":"10.1016\/j.ymthe.2005.09.022_bib9","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1089\/hum.1998.9.4-497","article-title":"Gene therapy with bilirubin-UDP-glucuronosyltransferase in the Gunn rat model of Crigler\u2013Najjar syndrome type 1","volume":"9","author":"Li","year":"1998","journal-title":"Hum. Gene Ther"},{"key":"10.1016\/j.ymthe.2005.09.022_bib10","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/sj.gt.3301729","article-title":"A non-immunogenic adenoviral vector, coexpressing CTLA4Ig and bilirubin-uridine-diphosphoglucuronateglucuronosyltransferase permits long-term, repeatable transgene expression in the Gunn rat model of Crigler\u2013Najjar syndrome","volume":"9","author":"Thummala","year":"2002","journal-title":"Gene Ther"},{"key":"10.1016\/j.ymthe.2005.09.022_bib11","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/lt.500040111","article-title":"Long-term reduction of serum bilirubin levels in Gunn rats by retroviral gene transfer in vivo","volume":"4","author":"Tada","year":"1998","journal-title":"Liver Transplant. Surg"},{"key":"10.1016\/j.ymthe.2005.09.022_bib12","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1006\/mthe.2001.0329","article-title":"Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages","volume":"3","author":"Zhang","year":"2001","journal-title":"Mol. Ther"},{"key":"10.1016\/j.ymthe.2005.09.022_bib13","doi-asserted-by":"crossref","first-page":"3930","DOI":"10.1073\/pnas.0500930102","article-title":"Lifelong elimination of hyperbilirubinemia in the Gunn rat with a single injection of helper-dependent adenoviral vector","volume":"102","author":"Toietta","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2005.09.022_bib14","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1006\/mthe.2001.0305","article-title":"A death in the laboratory: the politics of the Gelsinger aftermath","volume":"3","author":"Carmen","year":"2001","journal-title":"Mol. Ther"},{"key":"10.1016\/j.ymthe.2005.09.022_bib15","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1126\/science.272.5259.263","article-title":"In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector","volume":"272","author":"Naldini","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2005.09.022_bib16","doi-asserted-by":"crossref","first-page":"9873","DOI":"10.1128\/JVI.72.12.9873-9880.1998","article-title":"Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery","volume":"72","author":"Zufferey","year":"1998","journal-title":"J. Virol"},{"key":"10.1016\/j.ymthe.2005.09.022_bib17","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1182\/blood.V96.3.1173","article-title":"Therapeutic levels of human factor VIII and IX using HIV-1-based lentiviral vectors in mouse liver","volume":"96","author":"Park","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2005.09.022_bib18","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S1525-0016(03)00073-X","article-title":"Efficient production of human FVIII in hemophilic mice using lentiviral vectors","volume":"7","author":"Kootstra","year":"2003","journal-title":"Mol. Ther"},{"key":"10.1016\/j.ymthe.2005.09.022_bib19","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ymthe.2004.01.015","article-title":"Long-term lowering of plasma cholesterol levels in LDL-receptor-deficient WHHL rabbits by gene therapy","volume":"9","author":"Kankkonen","year":"2004","journal-title":"Mol. Ther"},{"key":"10.1016\/j.ymthe.2005.09.022_bib20","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1006\/mthe.2001.0276","article-title":"Transduction of liver cells by lentiviral vectors: analysis in living animals by fluorescence imaging","volume":"3","author":"Pfeifer","year":"2001","journal-title":"Mol. Ther"},{"key":"10.1016\/j.ymthe.2005.09.022_bib21","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1182\/blood-2003-09-3217","article-title":"Targeting lentiviral vector expression to hepatocytes limits transgene-specific immune response and establishes long-term expression of human antihemophilic factor IX in mice","volume":"103","author":"Follenzi","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2005.09.022_bib22","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1172\/JCI200316887","article-title":"Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transfer","volume":"111","author":"Mingozzi","year":"2003","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.ymthe.2005.09.022_bib23","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S1525-0016(03)00234-X","article-title":"Long-term correction of bilirubin UDPglucuronyltransferase deficiency in rats by in utero lentiviral gene transfer","volume":"8","author":"Seppen","year":"2003","journal-title":"Mol. Ther"},{"key":"10.1016\/j.ymthe.2005.09.022_bib24","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.ymthe.2005.06.482","article-title":"Therapeutic lentivirus-mediated neonatal in vivo gene therapy in hyperbilirubinemic Gunn rats","volume":"12","author":"Nguyen","year":"2005","journal-title":"Mol. Ther"},{"key":"10.1016\/j.ymthe.2005.09.022_bib25","first-page":"837","article-title":"Conditional immortalisation of Gunn rat hepatocytes: an ex vivo model for evaluating methods for bilirubin-UDP-glucuronosyltransferase gene transfer","volume":"21","author":"Fox","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.ymthe.2005.09.022_bib26","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1097\/01.TP.0000118404.66106.E8","article-title":"Gene therapy for organ grafts using rapid injection of naked DNA: application to the rat liver","volume":"77","author":"Inoue","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.ymthe.2005.09.022_bib27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/nbt0102-53","article-title":"Production of human clotting Factor IX without toxicity in mice after vascular delivery of a lentiviral vector","volume":"20","author":"Tsui","year":"2002","journal-title":"Nat. Biotechnol"},{"key":"10.1016\/j.ymthe.2005.09.022_bib28","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0958-1669(98)80029-3","article-title":"Lentiviruses as gene transfer agents for delivery to non-dividing cells","volume":"9","author":"Naldini","year":"1998","journal-title":"Curr. Opin. Biotechnol"},{"key":"10.1016\/j.ymthe.2005.09.022_bib29","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1182\/blood.V100.3.813","article-title":"Lentiviral vectors containing the human immunodeficiency virus type-1 central polypurine tract can efficiently transduce nondividing hepatocytes and antigen-presenting cells in vivo","volume":"100","author":"VandenDriessche","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2005.09.022_bib30","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1182\/blood-2001-11-0067","article-title":"Dangerous liaisons: the role of \u201cdanger\u201d signals in the immune response to gene therapy","volume":"100","author":"Brown","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2005.09.022_bib31","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1006\/mthe.2001.0330","article-title":"Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors","volume":"3","author":"Schnell","year":"2001","journal-title":"Mol. Ther"},{"key":"10.1016\/j.ymthe.2005.09.022_bib32","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1089\/10430349950017455","article-title":"Use of a liver-specific promoter reduces immune response to the transgene in adenoviral vectors","volume":"10","author":"Pastore","year":"1999","journal-title":"Hum. Gene Ther"},{"key":"10.1016\/j.ymthe.2005.09.022_bib33","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1182\/blood-2002-03-0823","article-title":"Therapeutic factor VIII levels and negligible toxicity in mouse and dog models of hemophilia A following gene therapy with high-capacity adenoviral vectors","volume":"101","author":"Chuah","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2005.09.022_bib34","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/1098-1004(200010)16:4<297::AID-HUMU2>3.0.CO;2-Z","article-title":"Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler\u2013Najjar and Gilbert syndromes: correlation of genotype to phenotype","volume":"16","author":"Kadakol","year":"2000","journal-title":"Hum. Mutat"},{"key":"10.1016\/j.ymthe.2005.09.022_bib35","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1101\/gad.1.3.268","article-title":"An albumin enhancer located 10 kb upstream functions along with its promoter to direct efficient, liver-specific expression in transgenic mice","volume":"1","author":"Pinkert","year":"1987","journal-title":"Genes Dev"},{"key":"10.1016\/j.ymthe.2005.09.022_bib36","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1089\/10430340252769770","article-title":"Efficient gene delivery and targeted expression to hepatocytes in vivo by improved lentiviral vectors","volume":"13","author":"Follenzi","year":"2002","journal-title":"Hum. Gene Ther"},{"key":"10.1016\/j.ymthe.2005.09.022_bib37","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1006\/mthe.2002.0630","article-title":"Biodistribution and toxicity studies of VSVG-pseudotyped lentiviral vector after intravenous administration in mice with the observation of in vivo transduction of bone marrow","volume":"6","author":"Pan","year":"2002","journal-title":"Mol. Ther"},{"key":"10.1016\/j.ymthe.2005.09.022_bib38","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1128\/JVI.76.3.1488-1495.2002","article-title":"Oncoretrovirus and lentivirus vectors pseudotyped with lymphocytic choriomeningitis virus glycoprotein: generation, concentration, and broad host range","volume":"76","author":"Beyer","year":"2002","journal-title":"J. Virol"},{"key":"10.1016\/j.ymthe.2005.09.022_bib39","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1089\/10430340360464723","article-title":"Large-scale production of pseudotyped lentiviral vectors using baculovirus GP64","volume":"14","author":"Kumar","year":"2003","journal-title":"Hum. Gene Ther"},{"key":"10.1016\/j.ymthe.2005.09.022_bib40","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nbt815","article-title":"Continuous high-titer HIV-1 vector production","volume":"21","author":"Ikeda","year":"2003","journal-title":"Nat. Biotechnol"},{"key":"10.1016\/j.ymthe.2005.09.022_bib41","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1089\/hum.2005.16.17","article-title":"Regulatory considerations for novel gene therapy products: a review of the process leading to the first clinical lentiviral vector","volume":"16","author":"Manilla","year":"2005","journal-title":"Hum. Gene Ther"},{"key":"10.1016\/j.ymthe.2005.09.022_bib42","doi-asserted-by":"crossref","first-page":"8150","DOI":"10.1128\/JVI.72.10.8150-8157.1998","article-title":"Development of a self-inactivating lentivirus vector","volume":"72","author":"Miyoshi","year":"1998","journal-title":"J. Virol"},{"key":"10.1016\/j.ymthe.2005.09.022_bib43","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/76095","article-title":"Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences","volume":"25","author":"Follenzi","year":"2000","journal-title":"Nat. Genet"},{"key":"10.1016\/j.ymthe.2005.09.022_bib44","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1128\/JVI.73.4.2886-2892.1999","article-title":"Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors","volume":"73","author":"Zufferey","year":"1999","journal-title":"J. Virol"},{"key":"10.1016\/j.ymthe.2005.09.022_bib45","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1128\/JVI.72.11.8463-8471.1998","article-title":"A third-generation lentivirus vector with a conditional packaging system","volume":"72","author":"Dull","year":"1998","journal-title":"J. Virol"},{"key":"10.1016\/j.ymthe.2005.09.022_bib46","doi-asserted-by":"crossref","first-page":"7297","DOI":"10.1073\/pnas.92.16.7297","article-title":"A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine","volume":"92","author":"Boussif","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2005.09.022_bib47","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1093\/clinchem\/29.10.1767","article-title":"Liquid-chromatographic assay and identification of mono- and diester conjugates of bilirubin in normal serum","volume":"29","author":"Muraca","year":"1983","journal-title":"Clin. Chem"},{"key":"10.1016\/j.ymthe.2005.09.022_bib48","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1006\/meth.2001.1220","article-title":"Fluorescence in situ hybridization analysis of transcript dynamics in cells","volume":"25","author":"van de Corput","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.ymthe.2005.09.022_bib49","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1023\/A:1013928600442","article-title":"Rapid and accurate determination of zygosity in transgenic animals by real-time quantitative PCR","volume":"11","author":"Tesson","year":"2002","journal-title":"Transgenic Res"},{"key":"10.1016\/j.ymthe.2005.09.022_bib50","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1172\/JCI114553","article-title":"Immunochemical analysis of uridine diphosphate-glucuronosyltransferase in four patients with the Crigler\u2013Najjar syndrome type I","volume":"85","author":"van Es","year":"1990","journal-title":"J. Clin. Invest"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001605016709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001605016709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T01:38:34Z","timestamp":1626831514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001605016709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S1525001605016709"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2005.09.022","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}